{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:47:58Z","timestamp":1788536878962,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54TR001012"],"award-info":[{"award-number":["U54TR001012"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54TR001012"],"award-info":[{"award-number":["U54TR001012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jtcvs.2015.08.039","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T17:16:12Z","timestamp":1439658972000},"page":"37-44.e1","source":"Crossref","is-referenced-by-count":87,"title":["Caprini venous thromboembolism risk assessment permits selection\u00a0for postdischarge prophylactic anticoagulation in\u00a0patients\u00a0with\u00a0resectable lung cancer"],"prefix":"10.1016","volume":"151","author":[{"given":"Krista J.","family":"Hachey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Hewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam P.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Ridyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McAneny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiran C.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia R.","family":"Litle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2015.08.039_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamasurg.2013.3172","article-title":"Venous thromboembolism after major cancer surgery: temporal trends and patterns of care","volume":"149","author":"Trinh","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e31821b98da","article-title":"Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis","volume":"254","author":"Merkow","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib4","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/j.1538-7836.2006.02153.x","article-title":"Prolonged prophylaxis with dalteparin to prevent late\u00a0thromboembolic complications in patients undergoing major abdominal\u00a0surgery: a multicenter randomized trial","volume":"4","author":"Rasmussen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","article-title":"Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review","volume":"135","author":"Hull","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2010.08.018","article-title":"Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients","volume":"212","author":"Pannucci","year":"2011","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.clinthera.2009.06.002","article-title":"Extended thromboprophylaxis with low-molecular weight heparins after hospital discharge in high-risk surgical and medical patients: a review","volume":"31","author":"Huo","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.thromres.2015.01.026","article-title":"Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010","volume":"135","author":"Nelson","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.soard.2007.11.010","article-title":"Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration,\u00a0dose stratification, and antifactor Xa activity","volume":"4","author":"Borkgren-Okonek","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/SLA.0b013e3181b7fca6","article-title":"A validation study of a retrospective venous thromboembolism risk scoring method","volume":"251","author":"Bahl","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jamcollsurg.2013.12.061","article-title":"Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program","volume":"218","author":"Cassidy","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ygyno.2014.04.051","article-title":"Validation of a venous thromboembolism risk assessment model in gynecologic oncology","volume":"134","author":"Stroud","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/hed.23411","article-title":"Venous thromboembolism in otolaryngology surgical inpatients receiving prophylaxis","volume":"36","author":"Yarlagadda","year":"2014","journal-title":"Head Neck"},{"issue":"2 Suppl","key":"10.1016\/j.jtcvs.2015.08.039_bib14","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.18553\/jmcp.2007.13.6.475","article-title":"Direct medical cost of venous thromboembolism and\u00a0subsequent hospital readmission rates: an administrative claims analysis\u00a0from 30 managed care organizations","volume":"13","author":"Spyropoulos","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.jtcvs.2015.08.039_bib17","doi-asserted-by":"crossref","first-page":"v274","DOI":"10.1093\/annonc\/mdq199","article-title":"ESMO Guidelines Working Group. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management","volume":"21","author":"Mandala","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jvs.2011.10.129","article-title":"Variation in thromboembolic complications among patients undergoing commonly performed cancer operations","volume":"55","author":"De Martino","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jvs.2014.08.055","article-title":"Care of patients undergoing vascular surgery at safety net public hospitals is associated with higher cost but similar mortality to nonsafety net hospitals","volume":"60","author":"Eslami","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cllc.2013.06.003","article-title":"Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients","volume":"14","author":"Connolly","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005373-200207000-00032","article-title":"Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group","volume":"53","author":"Rogers","year":"2002","journal-title":"J Trauma"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(97)08140-3","article-title":"Value of assessment of pretest probability of deep-vein thrombosis in clinical management","volume":"350","author":"Wells","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib24","series-title":"FDA expands use of Xarelto to treat, reduce recurrence of blood clots. [news release]","year":"2012"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib25","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomized controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/VHRM.S54714","article-title":"Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty","volume":"10","author":"Levitan","year":"2014","journal-title":"Vasc Health and Risk Manag"},{"key":"10.1016\/j.jtcvs.2015.08.039_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/11599370-000000000-00000","article-title":"Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a US payer's perspective","volume":"30","author":"Duran","year":"2012","journal-title":"Pharmacoeconomics"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522315014865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522315014865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T06:11:06Z","timestamp":1617603066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522315014865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0022522315014865"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2015.08.039","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}